StockNews.AI
MRK
StockNews.AI
141 days

Merck & Co., Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights – MRK

1. Shareholders may seek recovery regarding misleading revenue forecasts for Gardasil. 2. Merck projected $11 billion sales from Gardasil by 2030, now deemed unreachable. 3. Stock price dropped over 9% after Merck halted Gardasil shipments to China. 4. Demand for Gardasil in China did not meet expectations, leading to inventory issues. 5. Shareholders can register for class action by April 14, 2025.

5m saved
Insight
Article

FAQ

Why Bearish?

The 9% decline in stock indicates investor loss of confidence and forecast accuracy. Historical instances show that similar misleading forecasts led to long-term stock depressions.

How important is it?

The class action context and significant stock price drop indicate heightened importance to MRK investors.

Why Short Term?

The immediate market reaction suggests quick impacts, but long-term effects depend on recovery in sales and investor confidence.

Related Companies

GSK
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. (NYSE: MRK). Shareholders who purchased shares of MRK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/merck-co-inc-loss-submission-form/?id=139441&from=3  CLASS PERIOD: February 3, 2022 to February 3, 2025 ALLEGATIONS: According to the complaint, defendants provided investors with material information concerning Merck’s expected revenue of $11 billion from sales of Gardasil by 2030. Defendants’ statements included, among other things, confidence in Merck’s purported ability to utilize successful consumer activation and education efforts on the benefits of Gardasil in order to drive demand and capitalize on eligible populations for vaccination, resulting in confidently optimistic reports and forecasts of Gardasil’s growth in China. The full truth finally emerged on February 4, 2025, when Merck announced it would no longer achieve the long-forecasted $11 billion in sales of Gardasil by 2030, as it would cease shipments of Gardasil to China “through at least midyear” to facilitate a “rapid reduction of inventory.” Defendants claimed this was necessitated by the continued over-inflation of overall channel inventories as demand in China for Gardasil had “not recovered to the level we had expected.” Following this news, Merck’s common stock declined dramatically. From a closing market price of $99.79 per share on February 3, 2025, Merck’s stock price fell to $90.74 per share on February 4, 2025, a decline of more than 9% in the span of just a single day. DEADLINE: April 14, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/merck-co-inc-loss-submission-form/?id=139441&from=3  NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of MRK during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 14, 2025. There is no cost or obligation to you to participate in this case. WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: dg@securitiesclasslaw.com Phone: (646) 453-8903

Related News